Oxford Science Enterprises
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Oxford Science Enterprises (OSE), formerly known as Oxford Sciences Innovation plc, is a distinctive venture firm established in partnership with the University of Oxford. Its core mission is to commercialize the groundbreaking research emerging from the university's world-leading departments by building and scaling innovative companies. OSE operates as an independent investment company, providing capital and strategic support to transform scientific discoveries into viable businesses across various high-growth sectors, ensuring that academic breakthroughs translate into real-world impact and economic value.
Investor Profile
Oxford Science Enterprises has backed more than 160 startups, with 10 new investments in the last 12 months alone. The firm has led 64 rounds, about 40% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Led 4 rounds in the past year.
- Typical check size: $1.3M – $12.7M.
Stage Focus
- Seed (41%)
- Series A (30%)
- Series B (14%)
- Series Unknown (8%)
- Series C (3%)
- Pre Seed (3%)
- Convertible Note (1%)
- Undisclosed (1%)
Country Focus
- United Kingdom (95%)
- United States (2%)
- The Netherlands (1%)
- Finland (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Medical
- Therapeutics
- Life Science
- Information Technology
- Artificial Intelligence (Ai)
- Quantum Computing
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
